Austrian Drug Dictionary WHO ATC
The Austrian Drug Dictionary WHO ATC in a nutshell
This database contains information about Austrian drugs, homeopathic and biological remedies stored in the Austria WHO ATC Database. It provides the following information:
- Marketing Authorisation Number and Marketing Authorisation Holder (MAH)
- Pharmazentralnummer (PZN) and package sizes
- Marketing status
- Shortages
- Clear classification according to the WHO ATC Code
- Possibility of pharmacological-therapeutic comparison via ATC
- Smart Product Characteristics (SmPC) and Package information leaflet (PIL)
It is possible to search for a medicinal product by trade name, Marketing Authorisation Number, Marketing Authorisation Holder, Pharmazentralnummer (PZN), active ingredients, ATC codes and other criteria.
Suitable for:
Pharma Industry, Pharma Trade, Health Insurance, Regulatory
Source: AGES
Vienna, Austria
Related subscription
This database can be accessed after purchasing the subscription package ‘Drug Dictionaries’, or ‘Premium’
These databases could also be interesting for you
Related posts
Pharma Pricing Germany: Navigating Costs, Compliance and Transparency
Pharmaceutical pricing in Germany is unique in Europe – offering initial free pricing yet governed by strict mechanisms like AMNOG benefit assessments, reference pricing, and rebate contracts. In this comprehensive guide, we explain pharma pricing in Germany for...
European Drug Pricing Database: Comprehensive Pricing Insights for Healthcare Professionals
Access to an accurate, up-to-date European drug pricing database is essential for healthcare professionals in Germany, Austria, and Switzerland. Whether you’re calculating reimbursement, comparing market prices, or sourcing alternatives during shortages, having...
Pharmaceutical Market Access Germany: Navigating Approval, Pricing, and Reimbursement
Pharmaceutical market access in Germany is a critical step for any drug developer aiming to tap into Europe’s largest pharmaceutical market. With a population of 84 million and annual pharmaceutical revenues exceeding €56.9 billion in 2021, Germany offers vast...
